BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2063844)

  • 1. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses.
    Alamartine E; Sabatier JC; Guerin C; Berliet JM; Berthoux F
    Am J Kidney Dis; 1991 Jul; 18(1):12-9. PubMed ID: 2063844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy.
    Nieuwhof C; Kruytzer M; Frederiks P; van Breda Vriesman PJ
    Am J Kidney Dis; 1998 Jun; 31(6):962-70. PubMed ID: 9631840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors affecting the long-term outcome of IgA nephropathy].
    Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and renal survival rates in IgA nephropathy.
    Kang SW; Choi KH; Park JH; Lee SW; Lee HY; Han DS; Seong SH; Jeong HJ; Choi IJ
    Yonsei Med J; 1995 Mar; 36(1):45-52. PubMed ID: 7740835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indicators of IgA nephropathy in the Chinese--clinical and pathological perspectives.
    Li PK; Ho KK; Szeto CC; Yu L; Lai FM
    Nephrol Dial Transplant; 2002 Jan; 17(1):64-9. PubMed ID: 11773464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.
    Haas M
    Am J Kidney Dis; 1997 Jun; 29(6):829-42. PubMed ID: 9186068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.
    Frimat L; Briançon S; Hestin D; Aymard B; Renoult E; Huu TC; Kessler M
    Nephrol Dial Transplant; 1997 Dec; 12(12):2569-75. PubMed ID: 9430853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hypertension in patients with idiopathic IgA nephropathy.
    Chen Y; Tang Z; Yang G; Shen S; Yu Y; Zeng C; Chen H; Liu ZH; Li LS
    Kidney Blood Press Res; 2005; 28(4):251-8. PubMed ID: 16340218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS; Györy AZ
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.
    Bonnet F; Deprele C; Sassolas A; Moulin P; Alamartine E; Berthezène F; Berthoux F
    Am J Kidney Dis; 2001 Apr; 37(4):720-7. PubMed ID: 11273871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients.
    D'Amico G; Colasanti G; Barbiano di Belgioioso G; Fellin G; Ragni A; Egidi F; Radaelli L; Fogazzi G; Ponticelli C; Minetti L
    Semin Nephrol; 1987 Dec; 7(4):355-8. PubMed ID: 3445015
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.